You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
UCB launches 320 mg/2 mL single-injection administration option for BIMZELX (bimekizumab-bkzx) in US
17 January 2025 - Biopharmaceutical company UCB (Euronext Brussels:UCB) announced on Thursday that it has launched a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX (bimekizumab-bkzx).This is in addition to...
17 January 2025 - Drug delivery technology company Concept Medical Inc announced on Thursday that the first patient has been enrolled in the 'MAGICAL BTK' randomised controlled trial of MagicTouch PTA Sirolimus Coated Balloon (SCB) versus s...
17 January 2025 - Australian biopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX) (Nasdaq: TLX) announced on Thursday that it has received a positive decision on the Marketing Authorisation Application (MAA) for its prostate cancer PET ...
17 January 2025 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) and pharmaceutical company Jiangsu Aosaikang Pharmaceutical Co Ltd (ASK Pharm) (SZ:002755) announced on Thursday that China's National Medical Products Admin...
16 January 2025 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that Health Canada has approved RYBREVANT (amivantamab) in combination with chemotherapy for the treatment of patients with locally advance...
16 January 2025 - UK-based life sciences company Avacta Group plc (AIM:AVCT) on Thursday announced positive data from the Phase 1a trial of AVA6000, its lead peptide drug conjugate, in patients with salivary gland cancer.The data demonstrated clinica...
16 January 2025 - US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Wednesday that it has received approval from the US Food and Drug Administration (FDA) for Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...